Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Fujian Haixi Pharmaceuticals Co Days Payable?
Fujian Haixi Pharmaceuticals CoHKSE:02637 +3.28%23 Days Payable is 58.66 as of Dec. 2025, which is 65% above its 10-year median of 35.46. GuruFocus rates HKSE:02637 with a GF Score™ of 23/100. The stock has 2 warning signs investors should review. Among 925 Drug Manufacturers companies, Fujian Haixi Pharmaceuticals Co ranks worse than 68.76% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fujian Haixi Pharmaceuticals Co Days Payable Chart
Fujian Haixi Pharmaceuticals Co Annual Data
Trend
Dec22
Dec23
Dec24
Dec25
Days Payable
28.09
20.59
42.83
58.66
Fujian Haixi Pharmaceuticals Co Semi-Annual Data
Dec22
Dec23
Dec24
Dec25
Days Payable
28.09
20.59
42.83
58.66
HKSE:02637 vs ZTS: Days Payable Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Fujian Haixi Pharmaceuticals Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fujian Haixi Pharmaceuticals Co Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Fujian Haixi Pharmaceuticals Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Fujian Haixi Pharmaceuticals Co's Days Payable falls into.
Fujian Haixi Pharmaceuticals Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fujian Haixi Pharmaceuticals Co (HKSE:02637) has a Days Payable of 58.66 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Fujian Haixi Pharmaceuticals Co and its competitors. This is 65% above median its historical median of 35.46. Over the past decade, Fujian Haixi Pharmaceuticals Co's Days Payable has ranged from 20.59 to 58.66. According to the industry distribution chart, Fujian Haixi Pharmaceuticals Co ranks #636 out of 925 companies in the Drug Manufacturers industry, placing it in the top 68.8%.
Is Fujian Haixi Pharmaceuticals Co's Days Payable too high?
Fujian Haixi Pharmaceuticals Co's current Days Payable of 58.66 is 65% above median its 10-year median of 35.46. Over the past 10 years, this metric has ranged from a low of 20.59 to a high of 58.66. The Drug Manufacturers industry median Days Payable is 88.94. Fujian Haixi Pharmaceuticals Co's value of 58.66 is 34% below this industry median. Based on the distribution chart, Fujian Haixi Pharmaceuticals Co ranks #636 out of 925 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Fujian Haixi Pharmaceuticals Co has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Fujian Haixi Pharmaceuticals Co's Days Payable compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Fujian Haixi Pharmaceuticals Co ranks #636 out of 925 companies for Days Payable. This places Fujian Haixi Pharmaceuticals Co in the lower half of its industry. The industry median Days Payable is 88.94. Fujian Haixi Pharmaceuticals Co's value of 58.66 is 34% below this benchmark. Historically, Fujian Haixi Pharmaceuticals Co's own Days Payable has ranged from 20.59 to 58.66 over the past decade. While the company's 10-year median is 35.46 vs. the industry median of 88.94, Fujian Haixi Pharmaceuticals Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 88.94, based on 925 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fujian Haixi Pharmaceuticals Co's current Days Payable of 58.66 is 34% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Fujian Haixi Pharmaceuticals Co and its competitors. For the Drug Manufacturers industry, the median Days Payable is 88.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fujian Haixi Pharmaceuticals Co's current Days Payable is 58.66, which is 65% above median its own 10-year median of 35.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fujian Haixi Pharmaceuticals Co stock overvalued right now?
Fujian Haixi Pharmaceuticals Co (HKSE:02637) has a current Days Payable of 58.66. The current Days Payable is 58.66, which is 65% above median its 10-year median of 35.46 and 34% below the Drug Manufacturers industry median of 88.94. Fujian Haixi Pharmaceuticals Co's overall GF Score™ is 23/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Fujian Haixi Pharmaceuticals Co (HKSE:02637), the current Days Payable is 58.66 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Fujian Haixi Pharmaceuticals Co Ltd is a commercial-stage pharmaceutical company that integrates R&D, production and sales capacities, with a pipeline of inventive drug candidates. It has a diversified product portfolio and pipeline in the fastest growing therapeutic areas in China. The company's commercialized product portfolio consisted of generic drugs for digestive system diseases, cardiovascular system diseases, endocrine system diseases, nervous system diseases and inflammatory diseases. Its inventive drug pipeline focuses on drug candidates in a variety of indications, including one potential first-in-class oncology drug candidate, one potential first oral drug therapy for wet age-related macular degeneration /diabetic macular edema /retinal vein occlusion.
23GF Score
Get the complete analysis for HKSE:02637
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02637 has been successfully added to your 
